| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 09/16/2004 | US20040180443 Methods for transfer of DNA segments |
| 09/16/2004 | US20040180440 Modified AAV |
| 09/16/2004 | US20040180422 Generating phage particles comprising heterologous coat proteins for use as tools in screening and identifying preferential protein ligands; drug screening |
| 09/16/2004 | US20040180403 Novel 33 phage vectors |
| 09/16/2004 | US20040180348 Method for surface display of proteins of genetic carriers |
| 09/16/2004 | US20040180333 Self-replicating RNA molecule from hepatitis C virus |
| 09/16/2004 | US20040180064 For immunizing a cat against a hemorrhagic feline calicivirus (hFCV) |
| 09/16/2004 | US20040179978 photocatalytic material used to selectively inactivate a specific biologically harmful substance that may be contained in a liquid or gas |
| 09/16/2004 | CA2517939A1 Peptides that specifically bind hgf receptor (cmet) and uses thereof |
| 09/16/2004 | CA2517601A1 Infectious flavivirus pseudo-particles containing functional prm-e envelope proteins |
| 09/16/2004 | CA2517327A1 Animal-free cell culture method |
| 09/15/2004 | EP1457565A1 Double-stranded cyclic dna capable of proliferating as artificial e. coli chromosome |
| 09/15/2004 | EP1457211A1 Recombinant vaccinia virus vaccine |
| 09/15/2004 | EP1456419A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 09/15/2004 | EP1456398A2 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna and use of recombinant hpivi in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 09/15/2004 | EP1456228A2 Method of isolation and purification of trypsin from pronase and use thereof |
| 09/15/2004 | EP1455840A2 Treatment of human cancer with adenoviral vector expressing tnf-alpha |
| 09/15/2004 | EP1064305B1 Recombinant virus |
| 09/15/2004 | EP0707644B1 Use of pharmaceutical compositions for the treatment of neurodegenerative diseases |
| 09/15/2004 | CN1529755A Novel bacterial phytases and method for producing same |
| 09/15/2004 | CN1528887A Tumour targeting bigene-virus structure method |
| 09/15/2004 | CN1528886A Method for estabiishing coronavirus external-internal model |
| 09/14/2004 | US6790612 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis C virus protease |
| 09/14/2004 | US6790449 Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins |
| 09/10/2004 | WO2004076619A2 New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 09/10/2004 | WO2004075911A1 Chemokine binding protein and use thereof |
| 09/10/2004 | WO2004075861A2 Recombinant adeno-associated virus production |
| 09/10/2004 | WO2004075836A2 STABILIZED HBc CHIMER PARTICLES AS THERAPEUTIC VACCINE FOR CHRONIC HEPATITIS |
| 09/10/2004 | WO2004031210A3 Optimized multi-epitope constructs and uses thereof |
| 09/10/2004 | WO2003092594A3 Adeno-associated viral vectors and methods for their production from hybrid adenovirus and for their use |
| 09/10/2004 | CA2516640A1 Stabilized hbc chimer particles as therapeutic vaccine for chronic hepatitis |
| 09/09/2004 | US20040177392 Crustaceans as production systems for therapeutic proteins |
| 09/09/2004 | US20040176583 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 09/09/2004 | US20040175398 Oral smallpox vaccine production and methods to evaluate safety, efficacy, and potency of orally delivered vaccine |
| 09/09/2004 | US20040175365 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 09/09/2004 | US20040175363 Defective recombinant adenovirus; treatment of neurodenerative, cardiovascular, brain, genetic, nervous system and respiratory system disorders; Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), atherosclerosis, and/or trisomy 2; adult respiratory distress syndrome; anticarcinogenic agents |
| 09/09/2004 | US20040175362 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 09/08/2004 | EP1454989A1 Infectious HCV pseudo-particles containing native functional E1 and E2 envelope proteins |
| 09/08/2004 | EP1454988A1 Infectious flavivirus pseudo-particles containing functional prM-E envelope proteins |
| 09/08/2004 | EP1454984A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 09/08/2004 | EP1454981A1 Infectious pestivirus pseudo-particles containing functional erns, E1, E2 envelope proteins |
| 09/08/2004 | EP1453957A2 Method of large scale production of hepatitis a virus |
| 09/08/2004 | EP1453956A1 Method for large scale production of virus antigen |
| 09/08/2004 | EP1453608A2 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 09/08/2004 | EP1453547A2 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/08/2004 | EP1453543A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 09/08/2004 | EP1453538A2 Method of purifying hepatitis a virus particles and vaccine preparation |
| 09/08/2004 | EP1453537A1 Composition for viral preservation |
| 09/08/2004 | EP1453536A1 Composition for the preservation of viruses |
| 09/08/2004 | EP1453535A2 Enveloped virus vaccine and method for production |
| 09/08/2004 | EP0892852B1 Encapsulated cells expressing cytochrome p450 for prodrug activation |
| 09/08/2004 | CN1527883A Leporipox-based vector vaccines |
| 09/08/2004 | CN1527722A Smallpox vaccine |
| 09/08/2004 | CN1527663A Novel pesticidal toxins |
| 09/08/2004 | CN1165342C Porcine reproductive and respiratory syndrome vaccine |
| 09/07/2004 | US6787520 Inactivating process for lipid envelopped virus, and new antivirus lipopeptides |
| 09/07/2004 | US6787360 Bacteriophage, a process for the isolation thereof, and a universal growth medium useful in the process thereof |
| 09/07/2004 | US6787333 Retrovirus isolated from humans |
| 09/07/2004 | US6787145 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 09/02/2004 | WO2004074507A2 Method to confer cell culture replication activity to different hepatitis c virus isolates |
| 09/02/2004 | WO2004074467A1 Inactivated nodavirus vaccine |
| 09/02/2004 | WO2004073736A1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same |
| 09/02/2004 | WO2004018627A3 Methods for propagating adenovirus and virus produced thereby |
| 09/02/2004 | WO2003095623A3 Genetically engineered cell lines and systems for propagating varicella zoster virus and methods of use thereof |
| 09/02/2004 | US20040171813 comprises homogenizing to produce a green juice, adjusting pH and heating, separating by centrifugation and/or resuspension, then chromatography |
| 09/02/2004 | US20040171807 involves engineering a recombinant shuttle vector comprising a nucleic acid cassette encoding prokaryotic green fluorescent protein (GFP) operably linked to regulatory sequences which permit its expression in a host cell |
| 09/02/2004 | US20040171569 that directs formation of a recombinant virus upon introduction into a cell |
| 09/02/2004 | US20040171535 Heparanase II, a novel human heparanase paralog |
| 09/02/2004 | US20040171159 Cell-specific adenovirus vector comprising EBV-specific promoter |
| 09/02/2004 | US20040171132 Comprises nucleotide sequences coding herpes virus glycoprotein for developing vaccine which prevents respiratory system disorders in poulty; veterinary medicine; genetic vaccines |
| 09/02/2004 | US20040170964 Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces |
| 09/02/2004 | US20040170649 uses optimal solvent systems such that the lipid envelope around the viral particle is dissolved while the viral particle remains intact; autologous vaccines |
| 09/02/2004 | US20040170646 Preferred are EB1 or EB14 cell; canary poxvirus containins a exogenous DNA sequence that encodes a tumor antigen, an antigen derived from a human pathogen, or a fragment thereof; vaccines |
| 09/02/2004 | US20040170607 Reducing viability of tumor cells by administering a virus; differential sensitivity using interferons |
| 09/02/2004 | CA2512930A1 Inactivated nodavirus vaccine |
| 09/01/2004 | EP1452599A1 Improved epitope displaying phage |
| 09/01/2004 | EP1452540A2 Molecular sequence of swine retrovirus and methods of use |
| 09/01/2004 | EP1451329A2 Genetic vaccine against human immunodeficiency virus |
| 09/01/2004 | EP1451328A2 Phytases and method for producing these phytases |
| 09/01/2004 | EP1450856A2 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 09/01/2004 | EP1450854A2 Vaccine |
| 09/01/2004 | EP0616640B1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 09/01/2004 | CN1526018A Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/01/2004 | CN1526012A A specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it |
| 09/01/2004 | CN1524952A False virosome vaccine with recombinant replicon of dengue fever virus as carrier |
| 09/01/2004 | CN1524951A Vaccine for human papiloma virus |
| 08/31/2004 | US6783983 Microfiltration; comprises tumor suppressor genes; gene therapy, vaccines |
| 08/31/2004 | US6783981 Capable of delivering anti-viral inhibitory rna molecules to target cells; gene therapy |
| 08/31/2004 | US6783977 Internal ribosome entry site and vector containing same |
| 08/31/2004 | US6783972 Methods for large-scale production of recombinant AAV vectors |
| 08/31/2004 | US6783952 Deleting portion of eukaryotic nucleotide sequence encoding cerebral cortical voltage-dependent calcium channel alpha 2 subunit yielding soluble secreted protein retaining affinity for (3h)gabapentin |
| 08/31/2004 | US6783939 Alphavirus vectors and virosomes with modified HIV genes for use in vaccines |
| 08/28/2004 | CA2421086A1 Chicken rna polymerase i promoter and its use |
| 08/26/2004 | WO2004072274A1 Virus-like particle vaccine containing dengue virus recombinant replicon as its carrier |
| 08/26/2004 | WO2004071324A2 Method to reduce, eliminate, or prevent bacterial pathogen colonization in eggs and/or poultry using bacteriophages |
| 08/26/2004 | WO2004045529A3 West nile virus vaccine |
| 08/26/2004 | WO2004000207A3 Toxin-phage bacteriocide antibiotic and uses thereof |
| 08/26/2004 | WO2003101397A3 Tetravalent dengue vaccines |
| 08/26/2004 | WO2002044334A3 Recombinant rsv virus expression systems and vaccines |
| 08/26/2004 | US20040166573 replicon RNAs are electroporated into permissive cells and are harvested from the surfaces of the cells using a salt wash in which the salt concentration is from about 0.2 to about 5 M sodium/calcium/magnesium/potassium chloride |